Kairos Pharma, Ltd. (KAPA) financials · $18.8M cap
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Kairos Pharma, Ltd. (KAPA) $18.8M cap.
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Income | -$5.57M | -$2.34M |
| Net Income | -$5.45M | -$2.60M |
| EPS (Diluted) | N/A | N/A |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $6.54M | $5.77M |
| Current Assets | $5.39M | $4.17M |
| Cash & Equivalents | $4.49M | $1.27M |
| Total Liabilities | $199.0K† | $992.0K |
| Current Liabilities | $199.0K | $992.0K |
| Shareholders' Equity | $6.34M | $4.78M |
| Retained Earnings | -$14.3M | -$8.81M |
† Total Liabilities: Derived: total assets minus shareholders’ equity (stored total liabilities equalled total assets, i.e. the liabilities-and-equity total).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$3.44M | -$3.96M |
| Financing Cash Flow | $6.66M | $5.13M |
| Net Change in Cash | $3.22M | $1.18M |
FAQ
What is KAPA P/E and revenue?
Kairos Pharma, Ltd. (KAPA) $18.8M cap.
What is KAPA revenue?
KAPA income-statement cache has no revenue figure yet.
Is KAPA profitable?
Kairos Pharma, Ltd. last cached net income is -$5.45M (FY2025).
What are KAPA total assets?
Kairos Pharma, Ltd. last cached total assets are $6.54M (FY2025).
What is KAPA free cash flow?
No cached cash-flow row for KAPA yet.
Not investment advice. Cached statements, not a live tape.